GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Similarly, the price of anti-diabetic medicines like Dapagliflozin also reduced significantly after the medicine went off patent in Feb. A combination drug of Sitagliptin 100 mg, Dapagliflozin 10 ...

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...